Active 0 6 0 6 O
urinary 7 14 7 14 B-chronic_disease
tract 15 20 15 20 I-chronic_disease
disease 21 28 21 28 I-chronic_disease
or 29 31 29 31 O
biopsy 32 38 32 38 B-treatment
of 39 41 39 41 I-treatment
the 42 45 42 45 I-treatment
prostate 46 54 46 54 I-treatment
within 55 61 55 61 O
the 62 65 62 65 O
past 66 70 66 70 B-upper_bound
6 71 72 71 72 I-upper_bound
weeks 73 78 73 78 I-upper_bound

American 0 8 79 87 B-clinical_variable
Urological 9 19 88 98 I-clinical_variable
Association 20 31 99 110 I-clinical_variable
Symptom 32 39 111 118 I-clinical_variable
Score 40 45 119 124 I-clinical_variable
greater 46 53 125 132 O
than 54 58 133 137 O
8 59 60 138 139 B-lower_bound

Any 0 3 140 143 O
prior 4 9 144 149 B-treatment
surgical 10 18 150 158 I-treatment
intervention 19 31 159 171 I-treatment
or 32 34 172 174 O
use 35 38 175 178 O
of 39 41 179 181 O
5 42 43 182 183 B-treatment
- 43 44 183 184 I-treatment
alpha 44 49 184 189 I-treatment
- 49 50 189 190 I-treatment
reductase 50 59 190 199 I-treatment
medical 60 67 200 207 I-treatment
intervention 68 80 208 220 I-treatment
for 81 84 221 224 O
BPH 85 88 225 228 B-chronic_disease

Any 0 3 229 232 O
serious 4 11 233 240 O
medical 12 19 241 248 O
condition 20 29 249 258 O
that 30 34 259 263 O
is 35 37 264 266 O
likely 38 44 267 273 O
to 45 47 274 276 O
impede 48 54 277 283 O
successful 55 65 284 294 O
completion 66 76 295 305 O
of 77 79 306 308 O
the 80 83 309 312 O
study 84 89 313 318 O
, 89 90 318 319 O
such 91 95 320 324 O
as 96 98 325 327 O
certain 99 106 328 335 O
mental 107 113 336 342 B-chronic_disease
disorders 114 123 343 352 I-chronic_disease
, 123 124 352 353 O
hypersensitivity 125 141 354 370 O
to 142 144 371 373 O
onabotulinumtoxinA 145 163 374 392 B-allergy_name
or 164 166 393 395 O
anesthetics 167 178 396 407 B-allergy_name
used 179 183 408 412 O
in 184 186 413 415 O
the 187 190 416 419 O
study 191 196 420 425 O
, 196 197 425 426 O
syncope 198 205 427 434 B-chronic_disease

Cancer 0 6 435 441 B-cancer
that 7 11 442 446 O
is 12 14 447 449 O
not 15 18 450 453 O
considered 19 29 454 464 O
cured 30 35 465 470 O

Current 0 7 471 478 O
diagnosis 8 17 479 488 O
of 18 20 489 491 O
acute 21 26 492 497 B-chronic_disease
or 27 29 498 500 I-chronic_disease
chronic 30 37 501 508 I-chronic_disease
prostatitis 38 49 509 520 I-chronic_disease
( 50 51 521 522 O
which 51 56 522 527 O
may 57 60 528 531 O
cause 61 66 532 537 O
LUTS 67 71 538 542 B-chronic_disease
that 72 76 543 547 O
mimic 77 82 548 553 O
BPH 83 86 554 557 B-chronic_disease
) 86 87 557 558 O

Documented 0 10 559 569 O
bacterial 11 20 570 579 B-chronic_disease
or 21 23 580 582 I-chronic_disease
acute 24 29 583 588 I-chronic_disease
prostatitis 30 41 589 600 I-chronic_disease
within 42 48 601 607 O
the 49 52 608 611 O
past 53 57 612 616 B-upper_bound
year 58 62 617 621 I-upper_bound

Eaton 0 5 622 627 B-chronic_disease
- 5 6 627 628 I-chronic_disease
Lambert 6 13 628 635 I-chronic_disease
syndrome 14 22 636 644 I-chronic_disease
, 22 23 644 645 O
hemophilia 24 34 646 656 B-chronic_disease
, 34 35 656 657 O
hereditary 36 46 658 668 B-chronic_disease
clotting 47 55 669 677 I-chronic_disease
factors 56 63 678 685 I-chronic_disease
deficiency 64 74 686 696 I-chronic_disease
, 74 75 696 697 O
or 76 78 698 700 O
bleeding 79 87 701 709 B-chronic_disease
diathesis 88 97 710 719 I-chronic_disease

Enrolled 0 8 720 728 O
in 9 11 729 731 O
another 12 19 732 739 B-treatment
treatment 20 29 740 749 I-treatment
trial 30 35 750 755 I-treatment
for 36 39 756 759 O
any 40 43 760 763 O
disease 44 51 764 771 O
within 52 58 772 778 O
the 59 62 779 782 O
past 63 67 783 787 B-upper_bound
30 68 70 788 790 I-upper_bound
days 71 75 791 795 I-upper_bound

Episode 0 7 796 803 O
of 8 10 804 806 O
unstable 11 19 807 815 B-chronic_disease
angina 20 26 816 822 I-chronic_disease
pectoris 27 35 823 831 I-chronic_disease
, 35 36 831 832 O
myocardial 37 47 833 843 B-chronic_disease
infarction 48 58 844 854 I-chronic_disease
, 58 59 854 855 O
transient 60 69 856 865 B-chronic_disease
ischemic 70 78 866 874 I-chronic_disease
attack 79 85 875 881 I-chronic_disease
, 85 86 881 882 O
or 87 89 883 885 O
cerebrovascular 90 105 886 901 B-chronic_disease
accident 106 114 902 910 I-chronic_disease
( 115 116 911 912 I-chronic_disease
stroke 116 122 912 918 I-chronic_disease
) 122 123 918 919 I-chronic_disease
within 124 130 920 926 O
the 131 134 927 930 O
past 135 139 931 935 B-upper_bound
6 140 141 936 937 I-upper_bound
months 142 148 938 944 I-upper_bound

For 0 3 945 948 O
those 4 9 949 954 O
with 10 14 955 959 O
a 15 16 960 961 O
PSA 17 20 962 965 B-clinical_variable
between 21 28 966 973 O
4 29 30 974 975 B-lower_bound
- 30 31 975 976 O
8 31 32 976 977 B-upper_bound
ng 33 35 978 980 I-upper_bound
/ 35 36 980 981 I-upper_bound
ml 36 38 981 983 I-upper_bound
, 38 39 983 984 O
the 40 43 985 988 O
PSA 44 47 989 992 O
elevation 48 57 993 1002 O
must 58 62 1003 1007 O
be 63 65 1008 1010 O
considered 66 76 1011 1021 O
to 77 79 1022 1024 O
be 80 82 1025 1027 O
from 83 87 1028 1032 O
a 88 89 1033 1034 O
benign 90 96 1035 1041 O
cause 97 102 1042 1047 O
in 103 105 1048 1050 O
the 106 109 1051 1054 O
opinion 110 117 1055 1062 O
of 118 120 1063 1065 O
the 121 124 1066 1069 O
PI 125 127 1070 1072 O

Has 0 3 1073 1076 O
taken 4 9 1077 1082 O
estrogen 10 18 1083 1091 B-treatment
, 18 19 1091 1092 O
androgen 20 28 1093 1101 B-treatment
, 28 29 1101 1102 O
any 30 33 1103 1106 O
drug 34 38 1107 1111 B-treatment
producing 39 48 1112 1121 I-treatment
androgen 49 57 1122 1130 I-treatment
suppression 58 69 1131 1142 B-treatment
, 69 70 1142 1143 O
or 71 73 1144 1146 O
anabolic 74 82 1147 1155 B-treatment
steroids 83 91 1156 1164 I-treatment
within 92 98 1165 1171 O
the 99 102 1172 1175 O
past 103 107 1176 1180 B-upper_bound
4 108 109 1181 1182 I-upper_bound
months 110 116 1183 1189 I-upper_bound

Has 0 3 1190 1193 O
taken 4 9 1194 1199 O
phenylephrine 10 23 1200 1213 B-treatment
, 23 24 1213 1214 O
pseudoephedrine 25 40 1215 1230 B-treatment
, 40 41 1230 1231 O
imipramine 42 52 1232 1242 B-treatment
, 52 53 1242 1243 O
an 54 56 1244 1246 O
anticholinergic 57 72 1247 1262 B-treatment
, 72 73 1262 1263 O
or 74 76 1264 1266 O
cholinergic 77 88 1267 1278 B-treatment
medication 89 99 1279 1289 I-treatment
within 100 106 1290 1296 O
the 107 110 1297 1300 O
past 111 115 1301 1305 B-upper_bound
2 116 117 1306 1307 I-upper_bound
weeks 118 123 1308 1313 I-upper_bound

History 0 7 1314 1321 O
of 8 10 1322 1324 O
bladder 11 18 1325 1332 B-chronic_disease
calculi 19 26 1333 1340 I-chronic_disease
( 27 28 1341 1342 I-chronic_disease
stones 28 34 1342 1348 I-chronic_disease
) 34 35 1348 1349 I-chronic_disease

History 0 7 1350 1357 O
or 8 10 1358 1360 O
current 11 18 1361 1368 O
evidence 19 27 1369 1377 O
of 28 30 1378 1380 O
carcinoma 31 40 1381 1390 B-cancer
of 41 43 1391 1393 I-cancer
the 44 47 1394 1397 I-cancer
prostate 48 56 1398 1406 I-cancer
or 57 59 1407 1409 O
bladder 60 67 1410 1417 B-cancer
, 67 68 1417 1418 O
pelvic 69 75 1419 1425 B-treatment
radiation 76 85 1426 1435 I-treatment
or 86 88 1436 1438 O
surgery 89 96 1439 1446 B-treatment
, 96 97 1446 1447 O
urethral 98 106 1448 1456 B-chronic_disease
stricture 107 116 1457 1466 I-chronic_disease
, 116 117 1466 1467 O
or 118 120 1468 1470 O
bladder 121 128 1471 1478 B-treatment
neck 129 133 1479 1483 I-treatment
obstruction 134 145 1484 1495 I-treatment

Known 0 5 1496 1501 O
primary 6 13 1502 1509 O
neurologic 14 24 1510 1520 B-chronic_disease
conditions 25 35 1521 1531 I-chronic_disease
such 36 40 1532 1536 O
as 41 43 1537 1539 O
multiple 44 52 1540 1548 O
sclerosis 53 62 1549 1558 B-chronic_disease
, 62 63 1558 1559 O
myasthenia 64 74 1560 1570 B-chronic_disease
gravis 75 81 1571 1577 I-chronic_disease
or 82 84 1578 1580 O
Parkinson 85 94 1581 1590 B-chronic_disease
's 94 96 1590 1592 I-chronic_disease
disease 97 104 1593 1600 I-chronic_disease
, 104 105 1600 1601 O
or 106 108 1602 1604 O
other 109 114 1605 1610 O
neurological 115 127 1611 1623 B-chronic_disease
diseases 128 136 1624 1632 I-chronic_disease
known 137 142 1633 1638 O
to 143 145 1639 1641 O
affect 146 152 1642 1648 O
bladder 153 160 1649 1656 O
function 161 169 1657 1665 O

Males 0 5 1666 1671 B-gender

Maximum 0 7 1672 1679 B-clinical_variable
urinary 8 15 1680 1687 I-clinical_variable
flowrate 16 24 1688 1696 I-clinical_variable
less 25 29 1697 1701 O
than 30 34 1702 1706 O
15 35 37 1707 1709 B-upper_bound
ml 38 40 1710 1712 I-upper_bound
/ 40 41 1712 1713 I-upper_bound
sec 41 44 1713 1716 I-upper_bound

Must 0 4 1717 1721 O
be 5 7 1722 1724 O
off 8 11 1725 1728 O
aspirin 12 19 1729 1736 B-treatment
, 19 20 1736 1737 O
NSAIDS 21 27 1738 1744 B-treatment
, 27 28 1744 1745 O
and 29 32 1746 1749 O
Coumadin 33 41 1750 1758 B-treatment
for 42 45 1759 1762 O
7 46 47 1763 1764 B-lower_bound
or 48 50 1765 1767 O
more 51 55 1768 1772 O
days 56 60 1773 1777 O
prior 61 66 1778 1783 O
to 67 69 1784 1786 O
onabotulinumtoxinA 70 88 1787 1805 B-treatment
injection 89 98 1806 1815 I-treatment

Overactive 0 10 1816 1826 B-chronic_disease
bladder 11 18 1827 1834 I-chronic_disease
without 19 26 1835 1842 O
obstructive 27 38 1843 1854 O
symptoms 39 47 1855 1863 O
( 48 49 1864 1865 O
i.e. 49 53 1865 1869 O
decrease 54 62 1870 1878 O
in 63 65 1879 1881 O
force 66 71 1882 1887 O
of 72 74 1888 1890 O
stream 75 81 1891 1897 O
, 81 82 1897 1898 O
hesitancy 83 92 1899 1908 O
, 92 93 1908 1909 O
intermittency 94 107 1910 1923 O
, 107 108 1923 1924 O
post 109 113 1925 1929 O
- 113 114 1929 1930 O
void 114 118 1930 1934 O
dribbling 119 128 1935 1944 O
) 128 129 1944 1945 O

Penile 0 6 1946 1952 B-treatment
prosthesis 7 17 1953 1963 I-treatment
or 18 20 1964 1966 O
artificial 21 31 1967 1977 B-treatment
urinary 32 39 1978 1985 I-treatment
sphincter 40 49 1986 1995 I-treatment
[ 50 51 1996 1997 O
placement 51 60 1997 2006 O
] 60 61 2006 2007 O

Postvoid 0 8 2008 2016 B-clinical_variable
Residual 9 17 2017 2025 I-clinical_variable
( 18 19 2026 2027 I-clinical_variable
PVR 19 22 2027 2030 I-clinical_variable
) 22 23 2030 2031 I-clinical_variable
greater 24 31 2032 2039 O
than 32 36 2040 2044 O
350 37 40 2045 2048 B-lower_bound
ml 41 43 2049 2051 I-lower_bound

Previous 0 8 2052 2060 O
exposure 9 17 2061 2069 O
to 18 20 2070 2072 O
onabotulinumtoxinA 21 39 2073 2091 B-treatment

Serum 0 5 2092 2097 O
prostate 6 14 2098 2106 B-clinical_variable
specific 15 23 2107 2115 I-clinical_variable
antigen 24 31 2116 2123 I-clinical_variable
( 32 33 2124 2125 I-clinical_variable
PSA 33 36 2125 2128 I-clinical_variable
) 36 37 2128 2129 I-clinical_variable
level 38 43 2130 2135 I-clinical_variable
greater 44 51 2136 2143 O
than 52 56 2144 2148 O
8 57 58 2149 2150 B-lower_bound
ng 59 61 2151 2153 I-lower_bound
/ 61 62 2153 2154 I-lower_bound
ml 62 64 2154 2156 I-lower_bound
( 65 66 2157 2158 O
Hybritech 66 75 2158 2167 B-treatment
) 75 76 2167 2168 O

Taking 0 6 2169 2175 O
aminoglycosides 7 22 2176 2191 B-treatment
or 23 25 2192 2194 O
any 26 29 2195 2198 O
drug 30 34 2199 2203 O
that 35 39 2204 2208 O
interfere 40 49 2209 2218 O
with 50 54 2219 2223 O
neuromuscular 55 68 2224 2237 B-treatment
transmission 69 81 2238 2250 I-treatment

This 0 4 2251 2255 O
decision 5 13 2256 2264 O
can 14 17 2265 2268 O
be 18 20 2269 2271 O
based 21 26 2272 2277 O
on 27 29 2278 2280 O
PSA 30 33 2281 2284 B-clinical_variable
velocity 34 42 2285 2293 I-clinical_variable
, 42 43 2293 2294 O
previous 44 52 2295 2303 B-treatment
TRUS 53 57 2304 2308 I-treatment
( 58 59 2309 2310 I-treatment
transrectal 59 70 2310 2321 I-treatment
ultrasound 71 81 2322 2332 I-treatment
) 81 82 2332 2333 I-treatment
biopsy 83 89 2334 2340 I-treatment
, 89 90 2340 2341 O
percent 91 98 2342 2349 O
free 99 103 2350 2354 O
PSA 104 107 2355 2358 O
, 107 108 2358 2359 O
or 109 111 2360 2362 O
other 112 117 2363 2368 O
clinical 118 126 2369 2377 O
estimations 127 138 2378 2389 O
in 139 141 2390 2392 O
keeping 142 149 2393 2400 O
with 150 154 2401 2405 O
sound 155 160 2406 2411 O
urologic 161 169 2412 2420 O
care 170 174 2421 2425 O

Two 0 3 2426 2429 O
documented 4 14 2430 2440 O
urinary 15 22 2441 2448 O
tract 23 28 2449 2454 O
infections 29 39 2455 2465 O
of 40 42 2466 2468 O
any 43 46 2469 2472 O
type 47 51 2473 2477 O
in 52 54 2478 2480 O
the 55 58 2481 2484 O
past 59 63 2485 2489 O
year 64 68 2490 2494 O
( 69 70 2495 2496 O
UTI 70 73 2496 2499 B-clinical_variable
defined 74 81 2500 2507 O
as 82 84 2508 2510 O
greater 85 92 2511 2518 O
than 93 97 2519 2523 O
100,000 98 105 2524 2531 B-lower_bound
colonies 106 114 2532 2540 I-lower_bound
per 115 118 2541 2544 I-lower_bound
ml 119 121 2545 2547 I-lower_bound
urine 122 127 2548 2553 O
from 128 132 2554 2558 O
midstream 133 142 2559 2568 O
clean 143 148 2569 2574 O
catch 149 154 2575 2580 O
or 155 157 2581 2583 O
catheterized 158 170 2584 2596 O
specimen 171 179 2597 2605 O
) 179 180 2605 2606 O

Uncontrolled 0 12 2607 2619 B-chronic_disease
diabetes 13 21 2620 2628 I-chronic_disease

Voided 0 6 2629 2635 B-clinical_variable
volume 7 13 2636 2642 I-clinical_variable
greater 14 21 2643 2650 O
than 22 26 2651 2655 O
125 27 30 2656 2659 B-lower_bound
ml 31 33 2660 2662 I-lower_bound

at 0 2 2663 2665 O
least 3 8 2666 2671 O
50 9 11 2672 2674 B-lower_bound
years 12 17 2675 2680 I-lower_bound
of 18 20 2681 2683 O
age 21 24 2684 2687 B-age

